Rock Springs Capital Management LP Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$4.1T
Holdings
104
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (104 positions)
| Stock | Value |
|---|---|
XLOXILIO THERAPEUTICS INC | $792K |
NVRO 2.75 04/01/25NEVRO CORP | $482K |
TLPHACELRX PHARMACEUTICALS INC | $233K |
NUVB/WSNUVATION BIO INC | $8K |
PreviousPage 2 of 2